Just another WordPress site
Investment Type: Venture Capital
Portfolio 5
| Date | Name | Website | Total Raised | Location |
| - | Reaction B... | reactionbi... | - | United Sta... |
| - | Knopp Bios... | knoppbio.c... | $19M | United Sta... |
| - | Celsense | celsense.c... | - | - |
| - | Crystalple... | crystalple... | - | - |
| - | Immunetric... | immunetric... | - | United Sta... |
Mentions in press and media 11
| Date | Title | Description | Source |
| 14.11.2012 | Drug developer advancing Phase 2 drug for Lou Gehrig’s disea... | Product: Its lead product is dexpramipexole for amyotrophic lateral sclerosis or Lou Gehrig’s diseas... | medcitynew... |
| 13.07.2012 | Biotechnology firm raising $30M to advance treatment for Par... | Since it forged a licensing deal with Biogen in 2010 for its ALS drug dexpramipexole, Knopp has doub... | medcitynew... |
| 06.06.2011 | LaunchCyte raises $1.1M to commercialize biotech discoveries | The latest funding, $1.055 million, comes in the form of equity and is anticipated to be part of a $... | medcitynew... |
| 22.06.2010 | LaunchCyte raises $1 million | By Brandon Glenn Biotechnology commercialization company LaunchCyte LLC raised nearly $1 million in... | massdevice... |
| 21.06.2010 | Biotech commercialization firm LaunchCyte raises nearly $1M | It’s unclear what plans LaunchCyte has for its latest round of funding. CEO Tom Petzinger didn’t ret... | medcitynew... |
| 25.09.2009 | Pittsburgh’s Knopp NeuroSciences raising $12.5 million for A... | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis... | medcitynew... |
| - | Drug developer advancing Phase 2 drug for Lou Gehrig’s disea... | Company name: Knopp Biosciences Industry: Biotechnology Location: Pittsburgh, Pennsylvania Produc... | medcitynew... |
| - | LaunchCyte raises $1.1M to commercialize biotech discoveries | Biotechnology commercialization company LaunchCyte has raised nearly $1.1 million in equity, accordi... | medcitynew... |
| - | Biotech commercialization firm LaunchCyte raises nearly $1M | Biotechnology commercialization company LaunchCyte LLC has raised just less than $1 million in debt,... | medcitynew... |
| - | Biotechnology firm raising $30M to advance treatment for Par... | A biotechnology company that has licensed a drug for the treatment of neurodegenerative disease amyo... | medcitynew... |
Show more